Sotagliflozin vs Dapagliflozin: A Systematic Review Comparing Cardiovascular Mortality.
Iyer Nandhini, Hussein Sally, Singareddy Sanjana, +4 more·Cureus
After the debut of the results of the effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF) and Sotagliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes (SCORED) trials at the American Heart Association's 2020 Scientific session, so…